These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 21937693
1. Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. Yau JW, Stafford AR, Liao P, Fredenburgh JC, Roberts R, Weitz JI. Blood; 2011 Dec 15; 118(25):6667-74. PubMed ID: 21937693 [Abstract] [Full Text] [Related]
2. In vitro comparison of the novel, dual-acting FIIa/FXa-inhibitor EP217609C101, unfractionated heparin, enoxaparin, and fondaparinux in preventing cardiac catheter thrombosis. Kaeberich A, Raaz U, Vogt A, Maedgefessel L, Neuhart E, Krezel C, Drouget L, Hauroeder B, Buerke M, Werdan K, Schlitt A. J Thromb Thrombolysis; 2014 Dec 15; 37(2):118-30. PubMed ID: 23821043 [Abstract] [Full Text] [Related]
3. Corn trypsin inhibitor coating attenuates the prothrombotic properties of catheters in vitro and in vivo. Yau JW, Stafford AR, Liao P, Fredenburgh JC, Roberts R, Brash JL, Weitz JI. Acta Biomater; 2012 Nov 15; 8(11):4092-100. PubMed ID: 22824529 [Abstract] [Full Text] [Related]
4. In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation. Linkins LA, Julian JA, Rischke J, Hirsh J, Weitz JI. Thromb Res; 2002 Sep 01; 107(5):241-4. PubMed ID: 12479885 [Abstract] [Full Text] [Related]
7. The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitro. Raaz U, Kaeberich A, Maegdefessel L, Buerke M, Busshardt M, Schubert S, Russ M, Plehn A, Ebelt H, Werdan K, Schlitt A. Thromb Haemost; 2010 Apr 01; 103(4):808-14. PubMed ID: 20174756 [Abstract] [Full Text] [Related]
9. In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profile. Gerotziafas GT, Chakroun T, Samama MM, Elalamy I. Thromb Haemost; 2004 Dec 01; 92(6):1296-302. PubMed ID: 15583737 [Abstract] [Full Text] [Related]
10. Impact of antithrombin deficiency on efficacy of edoxaban and antithrombin-dependent anticoagulants, fondaparinux, enoxaparin, and heparin. Fukuda T, Kamisato C, Honda Y, Matsushita T, Kojima T, Furugohri T, Morishima Y, Shibano T. Thromb Res; 2013 Jun 01; 131(6):540-6. PubMed ID: 23673387 [Abstract] [Full Text] [Related]
11. Fondaparinux and enoxaparin in comparison to unfractionated heparin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model. Schlitt A, Buerke M, Hauroeder B, Peetz D, Hundt F, Bickel C, Schaefer I, Meyer J, Rupprecht HJ. Thromb Haemost; 2003 Aug 01; 90(2):245-51. PubMed ID: 12888871 [Abstract] [Full Text] [Related]
19. Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis. Kalicki RM, Aregger F, Alberio L, Lämmle B, Frey FJ, Uehlinger DE. Thromb Haemost; 2007 Dec 01; 98(6):1200-7. PubMed ID: 18064314 [Abstract] [Full Text] [Related]